Voleon Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Voleon Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$229K	Buy	+513	New	+$239K	﹤0.01%	715
2025 Q4	–	Sell	-10,830	Closed	-$4.24M	–	1034
2025 Q3	$4.24M	Buy	10,830 +8,137	+302%	+$3.4M	0.1%	196
2025 Q2	$1.2M	Sell	2,693 -3,060	-53%	-$1.41M	0.07%	224
2025 Q1	$2.79M	Sell	5,753 -7,475	-57%	-$3.48M	0.22%	113
2024 Q4	$5.33M	Buy	+13,228	New	+$6.13M	0.4%	68
2021 Q1	–	Sell	-165,000	Closed	-$39M	–	37
2020 Q4	$39M	Buy	+165,000	New	+$37.9M	4.17%	6
2019 Q4	–	Sell	-44,000	Closed	-$7.45M	–	236
2019 Q3	$7.45M	Buy	+44,000	New	+$7.78M	0.57%	40

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Voleon Capital Management's VRTX Position: Q1 2026 in Review

Voleon Capital Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 513 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #715 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in VRTX as recently as Q3 2025.

Voleon Capital Management first reported a position in VRTX in Q3 2019 and has held it in 7 quarters since. The position peaked at $39M in Q4 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Voleon Capital Management held 513 shares of Vertex Pharmaceuticals worth $229K as of Q1 2026.
Vertex Pharmaceuticals was a new Voleon Capital Management position in Q1 2026.
Vertex Pharmaceuticals made up ﹤0.01% of Voleon Capital Management's portfolio in Q1 2026, its #715 holding.
Voleon Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 7 quarters since.
Voleon Capital Management's Vertex Pharmaceuticals position peaked at $39M in Q4 2020.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.